Lelly Winduhani Astuti
Unknown Affiliation

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

PROFIL SWAMEDIKASI PADA MAHASISWA S1 FARMASI INSTITUT ILMU KESEHATAN BHAKTI WIYATA Esti Ambar Widyaningrum; Fentyana Dwi Rilawati; Lelly Winduhani Astuti; Rizki Nur Muhammad Aviantara
JURNAL PHARMA BHAKTA Vol 2 No 1 (2022): Juni 2022
Publisher : FAKULTAS FARMASI, INSTITUT ILMU KESEHATAN BHAKTI WIYATA

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Latar belakang : Swamedikasi atau pengobatan sendiri merupakan bagian dari upaya masyarakat untuk menjaga kesehatannya sendiri. Swamedikasi berarti mengobati segala keluhan pada diri sendiri dengan obat obat bebas dan bebas terbatas yang bisa dibeli bebas di apotik atau toko obat atas inisiatif sendiri tanpa nasihat dokter. Dalam pelaksanaannya, masyarakat harus memiliki pengetahuan yang memadai sehingga bisa berpraktik swamedikasi yang rasional sehingga bisa memperoleh manfaat serta terhindar dari risiko atau kerugian. Tujuan : Penelitian ini bertujuan untuk mengetahui profil swamedikasi di kalangan Mahasiswa S1 Farmasi Institut Ilmu Kesehatan Bhakti Wiyata Kediri Periode September 2020. Metode : Penelitian deskriptif observasional dengan rancangan survey cross sectional. Teknik sampling yang digunakan yaitu purposive sampling dengan sampel sebanyak 87 responden. Hasil : Profil swamedikasi pada penelitian ini adalah mayoritas responden berjenis kelamin perempuan (80,5%) dan berusia 17-19 tahun (50,6%). Alasan terbanyak melakukan swamedikasi adalah karena keluhan ringan (57,5%) dengan keluhan terbanyak demam (14,9%) dan flu (12,6%). Sumber informasi terbanyak adalah dari buku kuliah dan pengalaman belajar (42,5%), tempat memperoleh obat di apotek (87,4%), mayoritas membaca aturan pakai, efek samping obat serta kadaluarsa
Pasien Infark Miokard Akut pada Studi Penggunaan Obat Anti Platelet di RSUD Gambiran Kota Kediri Lelly Winduhani Astuti; Fitria Wahyuning Wulan; Nadya Bella Donna
Jurnal Medika Nusantara Vol. 2 No. 1 (2024): Februari : Jurnal Medika Nusantara
Publisher : Stikes Kesdam IV/Diponegoro Semarang, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59680/medika.v2i1.923

Abstract

The purpose of this study was to determine the pattern of drug use, potential interactions, and side effects of antiplatelet drugs in acute myocardial infarction patients in inpatient installations to reduce morbidity and mortality rates at Gambiran Hospital, Kediri City. This study is a non-experimental study with descriptive research design and retrospective data collection, data collection using purposive sampling method. Retrospective data collection based on medical record data of patients with acute myocardial infarction, this research was conducted from January to December 2020, so that the pattern of use of anti-platelet drugs in patients with acute myocardial infarction was a combination of aspirin 80 mg 1x1 with clopidogrel 75mg 1x1 (93%), with the route of drug administration orally. Analysis of potential drug interactions was carried out using the Drugs Interaction Checker and obtained 4 occurrences of major potential interactions and 10 occurrences of moderate potential interactions. The desired potential drug interaction was to prevent platelet aggregation. There was an undesirable potential drug interaction related to decreased antihypertensive effect of the drug, while potential drug interactions in the form of gastrointestinal bleeding and decreased renal function could not be determined.
The Rational Use of Human Serum Albumin and its Clinical Outcomes in Hospitalized Hypoalbuminemic Patients Zida Naswa Febriana; Fitria Wahyuning Wulan; Shofiatul Fajriyah; Ade Giri Ayu Anjani; Lelly Winduhani Astuti; Erni Anika Sari
MEDFARM: Jurnal Farmasi dan Kesehatan Vol 15 No 1 (2026): Medfarm: Jurnal Farmasi dan Kesehatan
Publisher : LPPM Akafarma Sunan Giri Ponorogo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.48191/medfarm.v15i1.803

Abstract

Background: Hypoalbuminemia is defined as a serum albumin level <3.5 g/dL, with clinically significant levels <2.5 g/dL associated with increased morbidity and mortality. Human Serum Albumin (HSA) is administered to increase serum albumin levels; however, its use requires evaluation to ensure rational prescribing and optimal therapeutic outcomes. Objective: This study aimed to evaluate the pattern of HSA use, analyze changes in serum albumin levels, and determine the relationship between the rationality of HSA use and albumin level achievement in hospitalized patients with hypoalbuminemia at Bhayangkara Hospital Kediri. Methods: This observational retrospective study used medical records of patients hospitalized from January to December 2025. A total of 32 patients meeting the inclusion criteria were selected using total sampling. Data were analyzed using the Paired t-test and Chi-Square test. Results: Most patients were male (59.37%), aged >60 years (65.63%), and hospitalized for <10 days (78.13%). Among patients receiving 20% HSA therapy, 28 patients (87.50%) received rational therapy, while 4 patients (12.50%) received irrational therapy based on the 2023 National Formulary criteria. Paired t-test analysis showed a significant increase in serum albumin levels after HSA administration (p<0.05). However, Chi-Square analysis showed no significant association between the rationality of HSA use and achievement of albumin level improvement (p>0.05). Conclusion: HSA therapy significantly increased serum albumin levels, although rationality of use was not significantly associated with albumin target achievement